The global rabies diagnostics market size is expected to
reach USD 2.03 billion by 2025 and is projected to expand at a CAGR of 4.1%
during the forecast period, according to a new report by Grand View Research,
Inc. Development of various diagnostic assays ranging from detection of virus
presence to final confirmation of infection helps launch effective disease
control programs. This factor is anticipated to drive the market growth. These
assays aid in defining epidemiologic patterns of the disease and thereby
deliver appropriate information for designing the control and eradication
programs. These programs have boosted the market growth by increasing the rate
at which testing kits are adopted.
For example, in June 2018, the World
Health Organization (WHO), the World Organization for Animal Health (OIE), the
Global Alliance for Rabies Control (GARC), and the Food and Agriculture
Organization of the United Nations (FAO) entered into a partnership for a plan,
The United Against Rabies Collaboration. This plan aims for rabies prevention
and management and empowering the under-served populations in afflicted
countries.
Furthermore, the state and public
health officials of the Department of Public Health and Human Services (DPHHS)
along with the Department of Livestock of Montana, U.S., deal with awareness
pertaining to the risk of virus exposure. They are engaged in training the
population about various aspects of disease management including prevention,
detection, and available treatment modes. Such initiatives are projected to
create growth opportunities for the rabies diagnostics market during the
forecast period.
Browse full research report on Rabies Diagnostics Market: https://www.grandviewresearch.com/industry-analysis/rabies-diagnostics-market
Further key findings from the report suggest:
- Fluorescent Antibody Test (FAT) held the largest market share
in terms of revenue owing to the high usage and recommendation by the WHO.
Great specificity, as compare to other conventional tests such as serology
and histology tests bodes well for the adoption of these tests
- Amplification methods are expected to supplant a major
portion of conventional methods, primarily due to several advantages
associated with the usage
- Currently, major products deploy ELISA/immunohistochemistry
techniques, resulting into a larger revenue share of this segment
- High prevalence of the disease in India and China coupled
with growing government support has contributed to the dominance of Asia
market over other regions
- Since, most of the countries in Europe are designated as
rabies free jurisdictions, the Europe market is anticipated to grow at the
slowest pace over the forecast period
- Bio-Rad Laboratories, Inc.; Merck KGaA; Aviva Systems Biology
Corporation; and Creative Diagnostics are some of the key entities in the
rabies testing market. The companies engage in developing products for
rabies eradication programs.
Browse
request sample of this report by Grand View Research:
Grand View Research has segmented the global rabies diagnostics
market on the basis of diagnostic method, technology, and region:
Rabies Diagnostics Diagnostic Method Outlook (Revenue, USD
Million, 2014 - 2025)
- Fluorescent
antibody test (FAT)
- Immunohistochemical
test
- Amplification
methods
- Histologic
examination
- Serology
tests
Rabies Diagnostics Technology Outlook (Revenue, USD Million, 2014
- 2025)
- ELISA/Immunohistochemistry
- Chromatography
techniques
- PCR
- Others
Rabies Diagnostics Regional Outlook (Revenue, USD Million, 2014 -
2025)
- North
America
- U.S.
- Canada
- Europe
- U.K.
- Spain
- Asia
Pacific
- India
- China
- Indonesia
- Latin
America
- Brazil
- Middle
East & Africa
- South
Africa
About
Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
For
more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment